Skip to main content
. 2023 Feb 24;6(2):e230122. doi: 10.1001/jamanetworkopen.2023.0122

Figure 1. Study Flow Diagram.

Figure 1.

EP indicates epirubicin plus paclitaxel; EC-P, epirubicin and cyclophosphamide followed by paclitaxel; ITT, intention to treat.